ROYAL BANK OF CANADA - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 28 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$0964
+3756.0%
0.00%
Q3 2022$0250.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 77,694$27,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 36,461$12,0000.00%
ROYAL BANK OF CANADA 25$00.00%
VANGUARD GROUP INC 616,855$216,0000.00%
Private Advisor Group, LLC 21,400$7,0000.00%
UBS Group AG 35,517$12,0000.00%
TWO SIGMA INVESTMENTS, LP 58,389$20,0000.00%
OSAIC HOLDINGS, INC. 8,321$3,0000.00%
FMR LLC 7$00.00%
WELLS FARGO & COMPANY/MN 1,005$00.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders